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Abstract
Background— During adult life, blood vessel formation is thought to occur via angiogenic 
processes involving branching from existing vessels. An alternate proposal suggests that neo-
vessels form from endothelial progenitors able to assemble the intimal layers. We here aimed to 
define vessel-resident endothelial progenitors in vivo in a variety of tissues in physiological and 
pathological situations such as normal aorta, lungs, as well as wound healing, tumors and 
placenta. 
Methods— Based on protein expression levels of common endothelial markers using flow 
cytometry, three sub-populations of endothelial cells could be identified among VE-Cadherin+ 
and CD45- cells. 
Results— Lineage tracing using Cdh5cre ERt2/Rosa-YFP reporter strategy demonstrated that the 
CD31-/loVEGFR2lo/intracellular endothelial population was indeed an endovascular progenitor 
(EVP) of an intermediate CD31intVEGFR2lo/intracellular transit amplifying (TA) and a 
definitive differentiated (D) CD31hiVEGFR2hi/extracellular population. EVP cells arose from 
vascular resident beds that could not be transferred by bone marrow transplantation. 
Furthermore, EVP displayed progenitor like status with a high proportion of cells in a quiescent 
cell cycle phase as assessed in wounds, tumors and aorta. Only EVP cells and not TA and D cells 
had self-renewal capacity as demonstrated by colony forming capacity in limiting dilution and by 
transplantation in MatrigelTM plugs in recipient mice. RNA sequencing revealed prominent gene 
expression differences between EVP and D cells. In particular, EVP cells highly expressed genes 
related to progenitor function including Sox9, Il33, Egfr and ????????Conversely, D cells highly 
expressed genes related to differentiated endothelium including Ets1&2, Gata2, Cd31, Vwf and 
Notch. The RNA sequencing also pointed to an essential role of the Sox18 transcription factor. 
SOX18’s role in the differentiation process was validated using lineage-tracing experiments 
based on Sox18CreERt2/Rosa-YFP mice. Besides, in the absence of functional SOX18/SOXF, 
EVP progenitors were still present, but TA and D populations were significantly reduced.  
Conclusions—Our findings support an entirely novel endothelial hierarchy, from EVP to TA to 
D, as defined by self-renewal, differentiation and molecular profiling of an endothelial 
progenitor. This paradigm shift in our understanding of vascular resident endothelial progenitors 
in tissue regeneration opens new avenues for better understanding of cardiovascular biology. 
Key Words: endothelial cell; angiogenesis; neovascularization; stem cell
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Clinical Perspective
What is new? 
? The discovery of an endovascular progenitor (EVP) cell in vivo that is present in normal 
endothelium (aorta, lung) and activated in vessel walls during various angiogenic 
situations (placenta, skin wound healing and tumors). 
? The molecular definition of an endothelial hierarchy from an EVP to a mature 
differentiated endothelial cell via complete RNA-sequencing
? Clarification of the lineage of endothelial progenitors and their origin, using bone 
marrow transplantation and vascular specific lineage tracing mouse models to 
demonstrate that EVPs are derived neither from bone marrow nor from hematopoietic 
progenitors. 
What are the clinical implications?
? Our study defines endothelial progenitors and is a major development into the 
understanding of how the vascular bed is able to remodel and/or regenerate during active 
angiogenesis in the adult.
? The discovery of an EVP will have significant implications for the development of 
endothelial progenitors as a cell therapy.
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Introduction
The vascular system is an essential component of tissue homeostasis as well as the response to 
injury, given its widespread presence in most tissues. During embryonic development, vessels 
form from the periphery of blood islands as separate units that end up joining in a process called 
vasculogenesis 1. However, in adults, formation of new blood vessels in response to insults or 
physiological signals is considered to result from the extension of existing vessels, defined as 
angiogenesis 2.
Neo-vessel formation has also been associated with activity of endothelial progenitors 
and their ability to assemble the intimal layers of mature vessels 1-4. This initiated the concept 
that an endothelial progenitor with capacity to self-renew and form blood vessels, not only exists 
in adult tissues but can be transferred to a new environment to form neo-vessels, potentially 
recapitulating some features of vasculogenesis. However, the definition, cell lineage and possible 
hierarchy of such precursors remain controversial 3, 5, 6.  
In particular, cells that promote angiogenesis, including myeloid cells and mesenchymal 
stem cells (MSC), have been often labeled as endothelial progenitors, despite their inability to 
form the endothelial layers of vessels de-novo 7, 8. In fact, vascular endothelial cells and 
hematopoietic cells found in adult tissues often share common markers 5, 9. Typically, positive 
surface expression of CD34, CD31 (PECAM1), VEGFR2 (flk1/KDR) and CD133 alone or in 
various combinations have been used to discriminate these progenitors 3, 10, 11, but are 
confounded by the presence of contaminating hematopoietic cells 5. Therefore, a definitive 
marker to isolate endothelial progenitors is lacking and thus their lineage, whether hematopoietic 
or not, remains controversial 12. It is therefore questionable whether a progenitor population with 
a unique potency to form new vessels exists in vivo.
 by guest on January 5, 2017
http://circ.ahajournals.org/
D
ow
nloaded from
 
10.1161/CIRCULATIONAHA.116.024754
5 
To address the existence and definition of such endothelial progenitors in vivo in adults, 
we hypothesized that the existence of a progenitor within the endothelial compartment would 
result in a hierarchy among endothelial cells that would be reflected in heterogeneity of their cell 
surface markers. Given their presumed capacity, we also assumed such cells would be 
particularly active in situations of neo-vessel formation in adults. Based on this approach, we 
here define at the molecular level, a novel endovascular progenitor in mice which recapitulates 
some features of vasculogenesis and document both its self-renewal in transplantation 
experiments and its vascular capacity in vivo using lineage tracing.  
Methods
Animals
All mice were treated in accordance with University of Queensland ethics approvals and 
guidelines for care of experimental animals. C57BL/6 mice (WT) (Animal Resources Centre, 
Perth, Western Australia), B6.Cg-Tg(Gt(ROSA)26Sor-EGFP)I1Able/J (ROSAeGFP) (The 
Jackson Laboratories, Bar Harbor, Maine, USA), and B6.SJL-PtprcaPep3b/BoyJArc (ptprc) 
(Animal Resources Centre, Perth, Western Australia) were used. For lineage tracing experiments 
Sox18-CreERt2 mice13 and Cdh5-creERt2 were crossed with B6.Cg-Gt(ROSA)26Sortm2(CAG-EYFP)Hze/J 
(ROSAloxYFPlox) The resultant double transgenic offspring were named Sox18-creERt2/ROSA-YFP
(8-12 weeks old) and Cdh5-creERt2/ROSA-YFP. For assessment of Sox18 function, Ragged 
Opposum (Sox18Op/+) mice and matched WT controls were used.   
In vivo wound healing assay 
Four full-thickness excisional wounds were generated down to the panniculus carnosus with a 
6mm sterile punch biopsy (Stiefel Laboratories Inc., Research Triangle Park, NC, USA). 
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Wounds were left open and animals sacrificed at defined time-points post-wounding. To induce 
Cre-mediated recombination of YFP, 2mg tamoxifen (Sigma-Aldrich, St Louis, MO, USA) was 
injected intra-peritoneally. This was conducted for three consecutive days (D-3) prior to 
wounding or on the day of wounding (D0). Animals were sacrificed at D1, D3 and D5 post 
wounding. 
In vivo tumor generation and Matrigel plugs 
For generation of tumors, 5 x 105 B16F0 were injected subcutaneously into flanks of 
ROSAeGFP mice. Tumors were grown for 10 days before harvesting host-derived (GFP+) cell 
populations by flow sorting. Matrigel™ (Becton Dickinson, NJ, USA) plugs were generated by 
sub-cutaneous injection of Matrigel™ (4mg/ml) mixed with vehicle or individual flow sorted 
cell populations into each flank of WT mice. To assess maturity of neovessels formed, 75μg 
FITC-conjugated Griffonia simplicifolia isolectin B4 (Vector laboratories, CA, USA) was 
injected retro-orbitally 10mins before sacrificing animals with Matrigel™ plugs or in Sox18
induced mice.
Bone marrow transplant 
To generate BM chimeras ROSAeGFP were used as donors to ensure all transplanted cells were 
labeled uniformly with GFP14. In short, 5-week-old ptprc recipients were lethally irradiated with 
a total body dose of 1000 cGy as described in previous literature 15. BM was harvested from the 
long bones of ROSAeGFP donors and a cell suspension containing 7 x 106 mononuclear cells 
administered via retro-orbital injection to irradiated recipients. After repopulation was 
confirmed, dorsal excisional wounds were generated on GFP+ BM chimeras. 
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Tissue processing of murine blood, bone marrow, placenta, aorta, wounds, tumors and 
Matrigel™ plugs from injured or uninjured animals.
Tissues were collected for ex vivo analyses at defined end points; wounds (D1-7), tumors (D10), 
Matrigel™ plugs (D3-14) and aorta (uninjured and D5). Total blood was collected via cardiac 
puncture, while one femur was flushed with a 27gauge needle and 5ml syringe to obtain total 
BM including endosteum. Excess skin surrounding individual wounds was removed and wounds 
were then minced through a 70μM cell strainer to generate single cell suspensions from wound 
granulation tissue. Red blood cells from total blood and BM preparations were lysed using a 
solution containing ammonium chloride, potassium bicarbonate and ethylenediaminetetraacetic 
acid (EDTA). Tumors and aorta were first digested for 1hr at 37°C in 1mg/ml collagenase I 
(Gibco, Life Technologies, NY, USA), 1mg/ml dispase (Gibco, Life Technologies, NY, USA), 
150μg/ml DNase-I (Sigma-Aldrich, St Louis, MO, USA) before passing the suspension through 
a 70μM cell strainer. Lineage+ cells were then depleted from tumor cell suspensions via 
MACS® cell separation according to the manufacturer’s instructions (Miltenyi Biotech,
Cologne, Germany).  Cell number and viability for each sample was assessed using 0.4% Trypan 
blue solution and a hemocytometer. Single cell suspensions were then used for flow sorting or 
analysis by flow cytometry.
Dissection of placentae from murine samples
Murine placentae were collected as previously described 16, 17. Briefly, uterine horns were 
dissected from pregnant dams (E10.5-E18.5 days post-conception (d.p.c)) and concepti separated 
from the endometrium. Using fine forceps, the decidua was peeled away from individual 
concepti, exposing the embryo and placenta, contained within the yolk sac. The yolk sac was 
carefully removed and GFP+ placentae were selected using a long wave-length UV lamp. The 
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placentae were then carefully separated from the embryos, minced and incubated for 2hrs at 
37°C with agitation as above before cell suspension prepared for analysis by flow cytometry 
RNA Extraction
RNA was extracted from sorted EVP, TA and D cells using a QIAGEN mini kit (Qiagen, 
Valencia, CA) according to the manufacturer’s instructions. RNA quality and concentration was 
assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Mulgrave, Victoria). 5-
100ng of RNA was used for cDNA synthesis using the Superscript III Reverse Transcription Kit 
(Invitrogen, Mount Waverley, Australia). 
Quantitative Polymerase Chain Reaction (qPCR)
Following cDNA synthesis, quantitative polymerase chain reaction (qPCR) assays were 
performed using SYBR® green chemistry according to manufacturers’ instructions (Applied 
Biosystems, Foster City, CA, USA). The primer sequences are listed in Supplementary Table S3.
RNA sequencing
Total isolated RNA of appropriate RIN (>4) was prepared using the TruSeq stranded total RNA 
library prep kit as per manufacturer’s instructions to be used in the Ilumina HiSeq2500 system 
by (Ilumina, San Diego, USA). 
RNA sequencing analysis
Sequence data were aligned to GRCm38 with STAR (version 2.5.0c), and read counts were 
calculated using the GENCODE gene annotation (release M9). Differential expression was 
calculated with DESeq2 (version 1.6.2) 18, 19. Significantly differentially expressed genes were 
selected by applied an FDR adjusted p-value cut off of p<0.05, and a log fold-change cut off of 
2.
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Flow Cytometry and FACS 
Dissociated single cells in PBS/BSA/EDTA were incubated with various antibody combinations 
for multi-parameter flow acquisition and analysis.  
A Gallios™ flow cytometer was used for sample acquisition while unbiased data analyses were 
performed with Kaluza® analysis software (Beckman-Coulter, Miami, Florida, USA). FACS 
was performed using a FACSaria cell sorter (Becton Dickinson, Franklin Lakes, NJ, USA). 
Extreme care was taken during cell sorting to ensure only ‘singlets’ were gated and any potential 
‘doublets’ were gated out. Cell populations were collected in 5ml polypropylene tubes 
containing 100% fetal calf serum (FCS) or RNA lysis buffer for RNA extraction. Single cell 
confocal flow analysis was performed using ImageStreamx (Amnis Seattle, WA, USA). For each 
population, 30,000 single cells were analyzed.  
The following combinations of antibodies were used to assess EPC populations: 
EPC Combination: Rat anti-mouse VE-Cadherin FITC, VEGFR2 PE, CD31 PE-Cy7, CD34 
Alexa647, and CD45 V450 (Becton Dickinson, NJ, USA). 
EPC Characterisation: Rat anti-mouse CD11b PerCP, Tie2 PE, CD105 PE, CD73 PE, Sca1 PE, 
CD90.2 FITC, CD146 FITC (Becton Dickinson, NJ, USA). 
EPC Cell cycle (Wounds, Aorta and Tumors): After first surface staining with the EPC panel, 
stained cells were fixed in 1% paraformaldehyde (PFA) and permeabilized in 1x Cytoperm 
buffer (Becton Dickinson, NJ, USA) before incubating in a solution containing 0.4mg/ml 4,6-
diamidino-2-phenylindole, (DAPI) (Life technologies, CA, USA).  
Immunohistochemistry
Dissected tissues were fixed for 2hrs in 4% PFA. The fixative was removed with 3x washes of 
PBS (Amresco, Solon, Ohio, USA). Tissues were subsequently infused with sucrose before cryo-
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embedding. For specific antigen staining, cryo-sections were permeabilized in 0.5% Triton-x-
100 (Chem Supply, Gillman, South Australia) before blocking with 20% normal goat serum. 
Paraffin-sections were deparaffinized and rehydrated. For this study, primary antibodies included 
rat anti-mouse CD31, rat anti-mouse VEGFR2, rat anti-mouse CD34, rat anti-mouse integrin ?6
(CD49f) (all from Becton Dickinson); rabbit anti-mouse LYVE-1, rabbit anti-GFP (both from 
Abcam, MA, USA). Isotype control antibodies included rabbit and rat IgG. Excess and unbound 
antibody was then removed with 3x 5min washes in a solution containing 1x PBS/0.1% Tween-
20 (Amresco, Solon, Ohio, USA). Secondary antibodies conjugated with Alexa-fluor 488 or 568 
(Invitrogen, Carlsbad, CA, USA) were used for fluorescence detection. Briefly, sections were 
incubated with secondary antibodies for 40mins at room temperature. Excess antibody was 
removed by 3x washes in PBS/0.1% Tween-20. Nuclear staining was revealed in specimens 
mounted with ProLong® Gold mounting media containing DAPI (Invitrogen, Carlsbad, CA, 
USA). Confocal images were acquired with a Zeiss LSM 710 microscope equipped with Argon 
561-10 nm DPSS and 633 nm HeNe lasers, and a 405-30 nm diode. We used the 405 nm diode 
laser for DAPI (detector 1, main beam filter MBS-405, 414–463-nm barrier filter), a 514-nm 
Argon line for YFP (detector 3, main beam filter MBS-458/514, 512-570-nm barrier filter) and 
the 561-nm photodiode laser for Alexa-568 (detector 3, main beam filter MBS-488/561, 562-
611-nm barrier filter). Images or z-stacks (videos) were acquired using 20x or 40x objectives.  
Whole mount wound preparation
Wound were excised on D5 as previously described before being fixed in 4% PFA for 2 h. 
Whole mount wounds approximately 5 mm thick were incubated at 4°C in FocusClear™ for 2 to 
5 days (Celexplorer Labs Co, Taiwan). Samples were then mounted in the same medium on 
single concave microscope slides (Sail Brand, China).
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In vitro colony formation assay: mouse 
Endothelial colony formation was assessed using 2D Matrigel™ assays20. EVP, TA and D were 
sorted from tumors and seeded in plates containing complete EGM2 (with 10%FCS) medium 
(Lonza Australia Pty Ltd, Victoria, Australia). Cells were maintained at 37°C within an IncuCyte 
system (Essen Biosciences Ltd, Hertfordshire, United Kingdom) and imaged frequently over 7 
days.
Mathematical modelling
Cell numbers from each population were modelled as absolute counts that could vary by 
proliferation, differentiation and apoptosis parameters. We compared two models: one with (A-
>B->C) and another without an intermediate population (A->B or C). Differentiation rates were 
used as variables to find the model that best fitted our experimental observations. Formulas are 
detailed in supplementary methods.
Statistical analysis 
Statistical analyses were performed using GraphPad Prism v5c software. Data were analyzed 
using the following tests: Mann Whitney (for non-normally distributed data), and t-tests and 1-
way or 2-way ANOVA with Bonferroni correction for normally distributed data. For the analysis 
of more than two groups with non-normally distributed data a Kruskal-Wallis was used with 
Dunn’s post-hoc correction. A p-value <0.05 was considered significant.
Results
Identification and characterization of distinct populations among endothelial cells during 
neo-vessel formation in adults 
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We examined situations of neo-vessel formation in adults to explore the heterogeneity of 
endothelial cells. In single cell suspensions from several tissue types (in particular skin wounds), 
we initially ascertained using multi-parameter flow cytometry for individual markers the 
threshold gating in combination for CD34, CD45, CD31, VEGFR2 and VE-Cadherin staining 
using a fluorescence minus one (FMO) approach (Figure 1A-B). From set thresholds we were 
able to exclude contaminating hematopoietic cells by gating out CD45+ cells and simultaneously 
track markers commonly associated with endothelial cells: VE-Cadherin, CD34, CD31 and 
VEGFR2. To ensure their endothelial nature, we used a Lineage cocktail antibody (CD3, CD11b, 
CD45, Gr-1 and Ter-119) to more robustly discriminate and eliminate hematopoietic and in 
particular myeloid cells. Among Lineage- cells, those expressing either VEGFR2 or CD31 were 
in fact CD34+ (>90%) (Supplementary Figure S1A-B). In addition, CD34+ cells not expressing 
CD45 were almost exclusively VE-Cadherin+, strongly suggesting their endothelial nature 
(Figure 1B). Among CD45-CD34+ cells, three distinct sub-populations could be defined by their 
cell surface expression levels of VEGFR2 and CD31 (Figure 1C). Based on FMO analyses of 
CD31 and VEGFR2 levels, these populations were either CD31loVEGFR2-/lo, 
CD31intVEGFR2-/lo or CD31hiVEGFR2hi (Figure 1C). For simplicity we label these 
populations as EVP (Figure 1C light blue), TA, (Figure 1C purple) and D (Figure 1C dark blue) 
respectively. Such populations could also be clearly distinguished based on their relative 
expression of CD34 and CD31 when only CD45- cells were gated, further underpinning the 
existence of three distinct populations. Both EVP and D cells were CD34hi, whereas TA cells 
were CD34lo, confirmed by measuring Mean-Fluorescence-Intensity (MFI) across multiple 
experiments (Supplementary Figure S1C). Further characterization confirmed that all three 
populations homogenously expressed other endothelial markers such as Tie2 at the cell surface 
 by guest on January 5, 2017
http://circ.ahajournals.org/
D
ow
nloaded from
 
10.1161/CIRCULATIONAHA.116.024754
13
(Supplementary Figure S1D; Table 1). Importantly, EVP cells did not express either 
mesenchymal (CD73) or pericyte (CD146) markers. In parallel, we also analyzed each 
population through flow-cytometry combined with quantitative image analysis (Amnis ®), 
which additionally validated the marker expression of each population (Supplementary Figure 
S1E). This also confirmed that all three populations had similar cell size and morphology in 
suspension. These cells differed from previously described populations of endothelial 
progenitors or mesoangioblasts, as they did not express c-kit and were unable to proliferate in 
mesenchymal-promoting media (data not shown)21, 22.   
 Following from the observations of our endothelial populations in injury/vessel formation 
situations, we obtained aorta from uninjured mice to analyze for these endothelial populations. 
Here, we showed by gating on all VECAD+CD45- cells from the aorta the same endothelial 
populations (EVP, TA and D) plotted as either CD34/CD31 or CD31/VEGFR2 (Supplementary 
Figure S1F). This further suggests that the populations are vessel resident and may play a role in 
vessel maintenance during homeostasis. Finally, we assessed the existence of all three 
endothelial populations over a range of additional murine situations of vessel remodeling and 
active neo-vessel formation such as placenta, and tumor development as well as basally in 
uninjured murine aorta and lungs (Figure 1D). On each occasion all three endothelial populations 
were observed with only slight variation in levels of each marker as expected due to different 
tissue processing techniques.
Intracellular expression of CD31 and VEGFR2 
We next evaluated whether the changes in CD31 or VEGFR2 levels reflected different cellular 
distribution of these surface markers and therefore assayed these populations for intracellular 
staining. The intracellular expression of CD31 remained consistent with membranous staining 
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confirming distinct populations based on discrete quantities of CD31 protein (CD31-/lo, CD31int 
and CD31hi) (Supplementary Figure S2A). However, VEGFR2 showed differential intracellular 
and cell surface levels. All three populations displayed VEGFR2 staining upon permeabilization 
although levels of CD31 did not differ. Image analysis (Amnis®) confirmed the vesicular 
distribution of intracellular VEGFR2 in each population (Supplementary Figure S2B). 
Furthermore, we quantified the intracellular versus membranous staining via image analysis 
using Amnis® to demonstrate clearly the observed difference in VEGFR2 expression between 
the two compartments, confirming the almost exclusive intracellular expression of VEGFR2 in 
EVP and TA populations (Supplementary Figure S2C; n=3). Overall, these results highlight 
differences between three populations of endothelial cells defined by their common expression of 
VE-Cadherin and absence of hematopoietic contamination. These three populations differ based 
on the level of CD34, CD31 as well as the cellular distribution and level of expression of 
VEGFR2 (n=3).
Kinetics of endothelial populations in wound angiogenesis
To decipher the contribution of these different endothelial populations to neo-vessel formation in 
adults, we explored their respective dynamics over time. Skin excisional wounds invariably form 
granulation tissue rich in CD31+VEGFR2+ vessels by day 5 (D5) post wounding, rendering this 
an attractive model to study the behavior of putative endothelial progenitors 23, 24 (Supplementary 
Figure S3A-C). In particular, the center of the granulation tissue remains devoid of any blood 
vessel up to D3-4 suggesting clearly that other vascularization processes than sprouting from 
vessels in the periphery of the wound can be studied in that area (Supplementary Figure S3C). 
The kinetics of endothelial populations in this setting proved dynamic and highly-reproducible 
(n>50) (Figure 2A). In gated CD45-CD34+ cells, the EVP population could be identified and 
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were predominant on D1-D2. TA but not D cells appeared more clearly from D2 in accordance 
with immunostaining on sections (Supplementary Figures S3A-B). From D3, all three 
populations were present. Expression levels of VEGFR2 and CD31 quantified by MFI were 
stable in each subpopulation over time, with the EVP population consistently negative and low 
for each marker respectively (Figure 2B). We examined the kinetics of all populations in the 
wound, both as absolute numbers and as proportion of CD34+CD45- cells (Figure 2C). 
Remarkably, the number of EVP cells remained low and did not vary from D2-5 (1-way 
ANOVA). TA and D cells increased in number, peaking on D5, in accordance with the expected 
peak of vascularization (p=0.03 and p=0.001 respectively compare to D1). Proportionally 
however, TA cells remained constant over time (1 way ANOVA) while D cells accumulated 
(p<0.001). This suggested that TA cells were an intermediate transit-amplifying population and 
that D cells were mature endothelial cells. This was supported by mathematical modelling where 
the best fit using the minimum mean square deviation method could be obtained for 24% of EVP 
cells differentiated into TA and 26% of TA cells differentiated into D at each increment of time 
(Supplementary Figures S4A-G; Supplementary Text; Supplementary Tables 1 & 2). In 
accordance, cell cycle analysis revealed that TA cells were more frequently in the S/G2/M phase 
in wounds but also in tumors and aorta (Figure 2D). Overall, the chronology of appearance, cell 
surface marker sequence, kinetics and mathematical modelling suggested a hierarchy and a 
differentiation sequence from EVP to D populations. 
Origin of endothelial populations  
Having established the heterogeneity of endothelial cells based on specific endothelial cell
markers, we next investigated the origin of EVP cells that first appear in the healing wound. It 
has been proposed that endothelial progenitors transit in the circulation potentially contributing 
 by guest on January 5, 2017
http://circ.ahajournals.org/
D
ow
nloaded from
 
10.1161/CIRCULATIONAHA.116.024754
16
to the pool of EVP cells at the beginning of the healing process. We first demonstrated that EVPs 
were of endothelial origin using a VE-Cadherin reporter (Cdh5-creERt2/ROSA-YFP) mouse. Prior 
to wounding (D0), tamoxifen was administered for three consecutive days (Days -3 to -1), thus 
labelling >80% of VE-Cadherin+ cells with YFP. Flow cytometry analysis of the granulation 
tissue of wounds harvested at D1, D3 and D5, showed that most EVP cells were labelled with 
YFP at every single time point suggesting that they derived from VE-cadherin expressing 
endothelial cells (Figure 3A; n=5). To address definitively the tissue source of EVP cells 
participating in wound healing, we employed a bone marrow (BM) transplantation model where 
recipients were reconstituted with GFP+ BM cells (Figure 3B). Although such experiments have 
been performed previously 25, the results were never analyzed using multi-marker flow 
cytometry to exclude confounding BM-derived myeloid cells that co-express endothelial 
markers. Repopulation success (over 93% GFP chimerism in the BM) was validated 8 and 13 
weeks post transplantation. Dorsal excisional wounds were then generated on chimeric 
recipients. All CD45-CD34+ cells present in wounds were GFP negative including the EVP, TA 
and D populations at both D1 and D5 post wounding, and 8 and 13 weeks after transplantation 
(Figure 3C). This indicated that BM does not contribute to endothelial cell populations and that 
these populations were neither contaminated by hematopoietic cells nor derived from them. As 
expected, CD45+ cells in wound granulation tissue were in part GFP+ (Figure 3C)26. Similarly,
on sections, all blood vessels (in red) present in the granulation tissue (Figure 3D) or uninvolved 
skin (not shown) at D5 were negative for GFP. Of 116 CD31+ vessels recorded in the 
granulation tissue, no GFP+ vessel was identified. Confocal microscopy at single cell level 
revealed potential co-localization events instead to be circulating GFP+ cells only. These data 
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confirm that cells that form new vessels during wound angiogenesis are endothelial-derived and 
unlikely to be transferred by bone marrow transplantation.
Self-renewal capacity of endothelial populations
We next explored whether the above defined populations differed functionally. To perform 
transplantation and in vitro culture experiments, we isolated EVP, TA and D populations from 
normal aorta and from tumors induced in CAG-GFP transgenic mice ubiquitously expressing 
GFP (Figure 4A). In limiting dilution in vitro culture experiments, flow-sorted GFP+ tumor-
derived or aorta-derived TA and D cells adhered and survived on Matrigel™ coated plates, but 
never proliferated. In contrast, isolated EVP cells clearly formed growing colonies over time and 
displayed tubes on their periphery. Quantification of the number of colonies per 1000 plated cells 
in limiting dilution assay robustly demonstrated that colony formation is a unique feature of the 
EVP cells only (Figures 4B-C). We estimated that the clonogenic capacity of an EVP to be 0.2-
0.3% of cells plated, which was consistent between both tumor and aorta. 
We next assessed the capacity of EVP, TA and D cells to self-renew and persist in vivo.
Strikingly, despite transplanting similar numbers of each population in Matrigel™ plugs that 
were further implanted in nude mice in vivo, markedly-reduced numbers of GFP+ TA or D cells 
were retrieved after 7 days, compared to the EVP population (n=5, p<0.01) (Figures 4D-E). 
Indeed when EVP cells were transplanted, they formed in a MatrigelTM assay mostly EVP cells 
and some TA cells with fewer D cells as expected (not shown). Sections of the Matrigel™ plug 
showed that injected EVP cells identified by their GFP label could form CD31+ or VE-
Cadherin+ vessels (Figure 4F). These data show that EVP cells are the only endothelial 
population with significant self-renewal potential and were therefore considered a potential 
endovascular progenitor. 
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Lineage tracing reveals endovascular progenitor mobilization in wound healing 
Although the chronology of appearance and self-renewal hierarchy suggested that EVP cells 
gave rise to the other 2 populations, this remained to be formally demonstrated. We therefore 
conducted lineage tracing experiments using the VE-Cadherin reporter (Cdh5-creERt2/ROSA-
YFP) mouse and only administered tamoxifen at the time of wounding (D0). This was used to 
limit the labelling to only the few EVP cells present in the center of wounds at this very early 
time-point. As flow cytometry analysis demonstrated, >95% of all endothelial cells 
CD34+CD45-YFP+ were EVP cells at D1 (Figure 5A; n=5). This was confirmed by 
immunofluorescence of D1 wounds showing individual CD34+ YFP cells in the center of the 
granulation tissue that did not stain for CD45, CD31 or VEGFR2 (Figure 5B; n=3). At D5, entire 
YFP+ vessels labelled with both VEGFR2 or CD31 were then observed in the center of the 
granulation tissue co-stained with CD31 (Figure 5C&D; n=3). This strongly suggests that TA 
and D cells associated with these blood vessels and further detected in flow cytometry (Figure 
5A), derived from the observed EVP cells in the center of the granulation tissue. Importantly no 
staining could be observed in the absence of tamoxifen injection or in mice lacking the Cre 
recombinase. These data confirm that vascular resident EVP mobilize during injury in the center
of the granulation tissue to initiate neo-vessel formation within a wound healing setting. This 
occurs through a differentiation process towards a transitional population that is actively cycling 
(TA) and ends with a terminally differentiated population (D) based on kinetics.
Major gene expression differences between endovascular progenitors versus terminally 
differentiated endothelial cells from aorta
To assess the molecular differences between EVP and D populations (n=2; each n-equates to cell 
populations pooled from 30 mice) we isolated these individual populations from the aortas of 
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uninjured WT mice. Total RNA was extracted, depleted of ribosomal RNA and finally 
sequenced and analyzed demonstrating comparable clustering within each population (Figure 
6A). Only genes that were >2 fold differentially expressed and with p<0.05 after multiple testing 
correction were gathered. This identified 860 genes identified as upregulated in D cells and 862 
genes upregulated in EVP cells.
Directly from the sequencing analysis, Pecam (CD31) and Kdr (VEGFR2) as expected 
were strongly upregulated in the D as opposed to the EVP population (>35 fold). Also Ptprc, the 
gene encoding for the common leucocyte antigen CD45 was not expressed in significant levels in 
any of the populations reflecting the absence of hematopoietic contamination. In fact, many 
genes in the D population related to endothelial differentiation. These included key endothelial 
transcription factors such as Ets1, Ets2, Gata2 and Fli1 and importantly identifiable endothelial 
cell surface and functional markers such as Cd31, Esam, Vwf, Tie1, Cldn5, and Enos. Using 
qPCR to validate genes of interest, all were upregulated >5 fold compared to the EVP population 
(***p<0.0001) (Figure 6B). D cells were also found to over-express Notch signaling target genes
(Dll1, Dll4, Hes1, Hey1), with all genes >5 fold upregulated compared to EVP (***p<0.0001; 
n=3). Lastly, the soxF family of genes including Sox7, Sox17 and Sox18 were observed as highly 
upregulated within the D population directly from RNA sequencing analysis. In fact, Sox18 was 
shown to be >200 fold higher. Each soxF gene was subsequently validated through qPCR, with 
all genes being >10 fold higher within the D endothelial population (***p<0.0001; n=3).  
 In stark contrast, EVP cells did not express many adhesion molecules, but instead had 
over-representation of matrix metalloproteases (MMP) and growth factor signaling important in 
cell motion. MMP genes upregulated (>2.5fold) within the EVP population included Mmp2,
Mmp3, Mmp14, Mmp19 and Mmp23. Among notable genes, growth factor pathways such as 
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Egfr, P????? and P??????were upregulated by 4, 20 and 6.5 fold respectively (Figure 6C), when 
compared with the D population (**p<0.01; n=3). Further to this, Il33, a known cytokine 
important in maintaining endothelial quiescence was also upregulated within the EVP population 
by 2 fold (**p<0.01; n=3), as was the transcription factor and known stem cell marker Sox9 27.
Using immunocytochemistry (n=3) to validate further some of the key genes identified, we 
demonstrated that IL33+ and SOX9+ staining was only observed on EVP cells (Figure 6D) and 
not on any D cells isolated through flow-sorting of normal aorta. However, when we stained for 
endothelial marker CD31, only D cells were positive (Figure 6D). This further validates our flow 
cytometry analysis demonstrating lack of CD31 cell surface expression among the EVP 
population. Nonetheless, EVP cells stained positively for VE-Cadherin as did D cells, 
demonstrating their isolation directly from a vascular source (Figure 6D).
Endovascular progenitors express Sox18 during wound revascularization
To further validate the gene expression differences obtained from RNA sequencing, we used 
another model to fate map the movement of EVP during a wound healing situation. The 
transcription factor SOX18 belongs to the SOXF group and is expressed in endothelial cell 
progenitors that instruct arterio-venous specification 28-30 and lymphatic endothelial cell fate 
during development 31. The expression of SOX18 is not found at adult stage and is only re-
activated in the endothelium under pathological conditions such as wound healing and tumor 
formation (Figure S5A)31-35. Given the strong differential expression of this gene between the D 
and EVP in normal aorta, we assumed that in a situation of active vessel formation, sox18 would 
be re-activated in those EVP cells entering transition towards a D differentiated fate. 
In Sox18-creERt2/Rosa-YFP reporter mice induced on a daily basis upon wound healing, YFP 
could only be visualized after tamoxifen induction (Supplementary Figure S5A) and was 
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restricted to CD31+ or VEGFR2+ expressing blood vessels at D3 and beyond (Supplementary 
Figure S5B). In particular, no expression could be observed in hair follicles if tamoxifen 
induction was performed after 3 weeks of age36. To address the timing of Sox18 re-expression 
upon wounding and the hierarchy of endothelial cell populations, tamoxifen was administered in 
subsequent experiments to reporter mice at the time of wounding (D0) to induce Cre-mediated 
recombination only in cells present at this time-point (Figure 7A). Analysis on D1 after 
wounding and tamoxifen injection revealed the presence of YFP+ cells within the CD45-CD34+ 
population. All these cells were VE-Cadherin+. YFP+ cells could not be found in CD45-CD34- 
populations or in the absence of Cre recombinase (Figure 7B). Expression pattern of VEGFR2 
and CD31 revealed that almost all YFP+ cells were from the EVP population at D1, with low 
CD31 and no surface VEGFR2 expression (Figure 7C). This confirmed that at least 30% of EVP 
cells at the beginning of the healing process, expressed Sox18. By D5, these YFP+ cells were 
still exclusively VE-Cadherin+ and all three populations, EVP, TA and D, could be observed 
suggesting the transition of EVP cells that re-activated Sox18 expression to TA and D cells. 
Although wound vasculature is also derived from existing vessels, these form only from the 
periphery towards the center and are unlikely to contribute at early time points to vessels within 
the center of the granulation tissue (Supplemental Figure 3). Quantitatively, YFP labelled EVP 
cells reduced over time, whereas D cells increased markedly in proportion in agreement with the 
wound kinetics in Figure 5. 
 These findings were also consistent with observations on tissue sections after 
immunostaining for endothelial cell markers. On D1 within the granulation tissue, sparse single 
YFP+ cells were large elongated cells with sizeable dendrites staining exclusively for CD34 but 
not CD31 VEGFR2 nor CD45, corresponding as expected to the re-expression of Sox18 in EVP 
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cells (Figure 7D). On D3 and D5, when looking at the center of the granulation tissue, these cells 
had formed vascular structures that expressed CD31 and VEGFR2 as TA and D cells (Figure 
7D-E). This validated our initial lineage tracing using Cdh5-creERt2/ROSA-YFP confirming that 
EVPs give rise to TA and D cells during neo-vessel formation. This further supported that YFP+ 
cells by flow cytometry (Figure 7B) and YFP+ vessels by D5 on sections (Figure 7F) represented 
similar proportions of the entire endothelial or vessel pool (about one third). Of note, YFP+ cells 
did not give rise to lymphatic vessels (LYVE1+) at D5.
We next injected isolectin B4 intravenously to label endothelial cells connected with the 
murine circulation. Isolectin B4 administered during wound healing on D3 labelled D cells and 
in part TA cells but not EVP cells by flow cytometry (Figure 7G). Similarly, isolectin B4 
injection 3 days post wounding in Sox18-creERt2/Rosa-YFP reporter mice induced at D0 with 
tamoxifen labelled only some YFP+ vessels reflecting different maturation status among YFP+ 
vessels derived from EVP cells (Figure 7H). This suggested a hierarchy of maturation as EVP 
containing vessels were not connected to the circulation and vessels containing D cells were 
mature and perfused.  
SOXF family activity is essential for de novo vessel formation 
Having established that Sox18 expressing EVP cells could give rise to TA and D cells, we finally 
assessed SOX18 function in this differentiation process. We used the Ragged Opposum
(Sox18Op/+) mouse which harbors a dominant-negative mutation of SOX18. This model is the 
most severe situation of loss of SOX18/SOXF function, and obviates rescue mechanisms via 
SOX7 or SOX17 that often obscure the functional assessment of this family 37, 38. Quantification 
of EVP, TA and D in Sox18Op/+ versus WT littermates revealed that although the number of EVP 
cells per wound was similar, there was a robust decrease in absolute numbers of TA and D cells 
 by guest on January 5, 2017
http://circ.ahajournals.org/
D
ow
nloaded from
 
10.1161/CIRCULATIONAHA.116.024754
23
at D3 and D5 post-wounding (p<0.001), highlighting the reduced ability of the progenitors to 
generate D cells (Figure 8A). Furthermore, on D5, CD31+ and VE-Cadherin vessels were 
identified only at the periphery of Sox18Op/+ wounds (Figure 8B) whereas granulation tissue of 
Sox18Op/+ mice was devoid of any neo-vessel compared to WT littermates. This suggested that 
neo-vessels originating from EVP in the center of the granulation tissue depended almost 
exclusively on SOXF activity to generate the fully differentiated D cells that harbor high levels 
of SOXF. 
Discussion
Repair and maintenance of the integrity of the vascular system after injury in adults has been 
deemed as relying solely on angiogenesis. This concept is challenged by the description of 
endothelial progenitors as an alternative source of neovessel formation. Others have pertained 
the concept of endothelial progenitors such as Ingram et al having previously observed the 
potential of endothelial precursors in human circulating blood and Naito et al describing the 
observation of an endothelial side population from numerous organ beds in mouse tissue6, 20.
However, the lack of definition of such cells has left many questions unanswered, challenging 
the validity of this newer paradigm, especially in mice. Here we show that upon injury, adult 
endothelial cells are heterogeneous and can be grouped into three populations based both on their 
lack of hematopoietic markers and on their expression levels of CD34, CD31 and VEGFR2. In 
the temporally-defined context of wound healing, these three populations appeared sequentially 
in quantities suggestive of a hierarchy, as confirmed by lineage tracing using the Cdh5-CreERt2/ 
ROSA-YFP. Furthermore, significant differences were observed in the gene expression make-up 
of EVP versus terminally-differentiated D cells. These differences readily defined each 
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population and further supported the ‘progenitor’ nature of an EVP cell. Sox18 re-expression was 
shown to be an initial event present in progenitors with significant functional importance. 
Importantly, individual progenitors found in the center of wounds could be followed at later time 
points towards immature and then mature vessels connected to the circulation. Finally, colony 
forming capacity in vitro and engraftment and self-renewal in vivo were limited to this progenitor 
population.  
Hierarchy not activation 
An important issue has been the definition of endothelial progenitors. Indeed our observed 
maturation hierarchy could simply represent a sequence of activation 39. Such hypothesis would 
however imply that any cell within the endothelial compartment would have an equal capacity to 
initiate an immature vessel as an EVP cell and go through the maturation hierarchy. We argue 
that the EVP cell population described here has inherent stem/progenitor cell characteristics. The 
evidence for this is that EVPs have a monopotent capacity to form definitive vessels even if 
injected as cells in suspension. Next, EVP cells have self-renewal capacity upon transfer in 
MatrigelTM plugs in vivo. In contrast, TA and D cells could not engraft in similar experiments nor 
could they produce EVP cells. Furthermore, EVP but not TA and D cells have in vitro colony 
forming capacity when isolated from either an active wound healing or basal aorta environment. 
This does not conflict with the relatively slow proliferation of EVP cells in vivo. Indeed, many 
described stem cell populations in the hematopoietic system or the skin are quiescent in vivo but 
have robust colony forming, proliferative and engraftment capacity 40, 41. Although the in vitro
clonogenic capacity of an EVP was approximately half compared to that of an endothelial side 
population as described by Naito et al20, colonies were still obtained on each occasion of plating. 
Insofar, the in vitro methods used to determine colony-formation were entirely different, which 
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may attribute to the potential differences observed.  The hierarchy described herein is thus not 
due to differential activation of these endothelial populations, but instead reflects an intrinsic cell 
characteristic that defines the EVP population as a stem/progenitor for the endothelial lineage.  
Cellular origin of EVPs
We investigated whether bone marrow was the primary source of these endothelial progenitors 
during tissue repair using bone marrow chimeras. We took precautions in our bone marrow 
studies to use large gauge needles to include in the transfer the endosteal tissue where 
endothelium is expected to be found 42. Similar to a previous study 25, we did not find donor 
derived blood vessels in wounds from bone marrow transplant recipients by confocal 
examination, and confirmed this using the more stringent criteria of flow cytometry. Using 
similar techniques, we reported previously donor-derived blood vessels in microchimeric 
situations, confirming our capacity to detect even rare events. In pregnant mice, fetal-derived 
endothelial CD34+CD45- progenitors formed entire blood vessels in wounds 43, inflamed skin 44
and tumors 45. Although, undeniably a rare-event situation, we were nevertheless able to find the 
vessels emanating from these distant progenitors 43. In the present study however, we could not 
find any donor-derived vessels, despite assessing a large number of sections, thus excluding any 
significant bone marrow or hematopoietic contribution to neo-vessel formation in this context.  
 Although the precise location of EVPs remains to be determined, we present evidence to 
suggest that these cells lie in existing vessels in the tissue surrounding the wound or the tumor. 
To address this question we used the vascular specific Cdh5-CreERt2/ ROSA-YFP, a gold standard 
mouse model in tracing vascular populations 46. This confirmed the migration of EVP cells into 
the center of the granulation tissue of D0 wounds. Furthermore, individual Sox18+ (YFP+) EVP 
cells could be identified at steady state or immediately upon wounding in uninjured vessels 
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surrounding the wound. It is highly likely that the EVP cells identified in the center of the wound 
derive from these isolated endovascular cells. Although wound vasculature is also derived from 
existing vessels, these act only from the periphery towards the center and are unlikely to 
contribute at early time points to vessels within the center of the granulation tissue. These data 
are in keeping with the increasing recognition of a population of vessel-resident endothelial 
progenitors 47, 48 and support the concept that local vessels, peripheral to the injury, could provide 
an immediate source of endothelial progenitors. 
Distinct gene expression of EVP versus definitively differentiated D populations
RNA sequencing of sorted populations from normal aorta ascertained that the D population was 
a clearly differentiated endothelial population, demonstrating strong expression of key markers 
classically defining endothelial cells and their function. This included the transcription factor 
genes that control endothelial cell development and maturation 49, 50. Collectively, there was also 
clear activation of the NOTCH pathway, which is indicative of the arterial phenotype but also 
instructive for the angiogenic pathway during tissue regeneration and endothelial cell 
proliferation 51, 52.  Most surprising was the identification of genes that delineated the EVP 
population. Many genes upregulated here were related to growth factor signaling, such as pdgf 
and egf. Both these pathways are potent activators in cell migration, stem cells populations, with 
roles in maintaining mesenchymal stem cell potency and self-renewal capacity, and in activating 
intestinal stem cells to mediate regenerative pathways 53, 54. Furthermore, MMP genes were 
significantly upregulated in the EVP population. MMPs are known to initiate cell migration by 
allowing cells to degrade the surrounding extracellular matrix as well as enhancing cell 
engraftment during tissue regeneration. This has been demonstrated in models of cardiac 
regeneration with cardiac stem cells and in vitro using mesenchymal stem cells 55, 56. We also 
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found here that EVP cells did not express hematopoietic markers and maintained low but 
significant levels of many endothelial markers usually absent in other mesenchymal populations 
such as CD31 or CD34.  
Sox18-dependent control of TA and D identity
Our results confirm activation of Sox18, as previously reported in adult wounds and tumors. The 
importance of sox18 transcription factor in the D population in normal endothelium as observed 
in the RNAseq analysis, was reflected in its expression in EVP cells potentially entering the 
differentiation process. Further studies are now indicated to identify the initial steps leading to 
selective activation of Sox18 in a limited number of resident endothelial cells. Functionally, 
dominant negative mutation of SOX18 led to a significant depletion of both the TA and D 
populations. However, we were unable to discern the consequences of TA and D deficiency on 
wound closure in the model used due to the lack of hair follicle development in Sox18op/+ mice. 
Although highlighting the functional importance of this transcription factor, the dominant 
negative nature of the mutation leaves open the possibility that SOX18 partners such as other 
SOXF family members may actually drive the observed function. Further studies need to address 
definitively the role of SOX18 binding partners in the transition from EVP to TA and D. 
Nevertheless, our study validates the functional importance of SOX18 and related partners in the 
hierarchy described here in endothelial cells.
 In conclusion, we here define a novel population of vessel resident EVPs participating in 
pathological and physiological neovessel formation. Their molecular definition and sequential 
differentiation forming immature and then definitive vessels provides important insights in the 
activity of endothelial progenitors in vivo. This opens new avenues into the contribution of EVPs 
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to tissue repair, raising the potential for therapeutic modulation. Future studies will now look at 
the potency of EVP beyond its endothelial capacities. 
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Table 1. Cell surface marker expression 
MARKER EVP TA D
VECAD +++ +++ +++
CD34 +++ + +++
CD31 -/+ ++ +++
VEGFR2 - + +++
CD45 - - - 
Tie2 +++ +++ +++
Alpha-6 - + +++
CD73 - - ++
CD105 - + +++
Sca1 +++ +++ +++
CD90.2 +++ +++ +++
CD146 - + +++
+ Positive Staining; - Negative Staining
EVP – Endovascular Progenitor;
TA – Transit Amplifying;
D – Definitive Differentiated
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Figure Legends
Figure 1? Identification and characterization of distinct populations among endothelial
cells in adults. A: Fluorescence-Minus-One (FMO) analyses were performed on cells from D5
wounds in order to set threshold for CD45 and CD34 positivity (dotted red line marks threshold). 
A clear population could be distinguished in the CD34+CD45- quadrant gated on live cells. 
B: All cells from the CD34+CD45- populations were shown to be vascular in origin as 
demonstrated by VE-Cadherin (VECAD) positivity. C: Fluorescence-Minus-One (FMO)
analyses were performed on endothelial CD34+CD45- cells in order to set threshold for CD31 
and VEGFR2 positivity. In gated CD34+CD45- cells, three distinct populations were observed 
based on CD31 and VEGFR2 expression in wounds (from left to right: EVP, TA and D; n>50). 
D: Gating on cells that are only CD34+CD45-VECAD+, the 3 endothelial populations can be 
demonstrated in four other angiogenic situations: aorta, lung, E18 placenta and tumors. EVP – 
Endovascular Progenitor; TA – Transit Amplifying; D – Definitive Differentiated
Figure 2? Kinetics of endothelial populations in wound angiogenesis. A: Gated on all CD34
+CD45- endothelial cells, days 1- 7 flow plots demonstrate the kinetics of EVP, TA and D cells
in skin wounds (n=3 to >50 per time point). B: Quantification of Mean-Fluorescence-Intensity
(MFI) values of CD31 and VEGFR2 further confirmed the stability of expression levels of these
endothelial markers in the three populations over time through the wound kinetic study (n=6).
Results presented as mean +/- SEM. C: Absolute numbers (left) (**p<0.01 vs EVP; n=6) and
relative proportions (right) of EVP, TA and D in 6mm punch biopsy wounds over time
(n=6). D: Cell cycle analysis using DAPI quantification of nucleic acids per cell demonstrated
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that more EVP cells were in G0/1 phase (###p<0.001 vs. TA; ***p<0.001 vs D) whereas more 
TA cells in the S+ G2/M phase (###p<0.001 vs. EVP; ***p<0.001 vs D n=6) from both wounds 
and tumors. Results presented as mean +/- SEM. EVP – Endovascular Progenitor; TA – Transit 
Amplifying; D – Definitive Differentiated
Figure 3? Origin of the endothelial populations. A: Schematic representation of the lineage 
tracing model employing the Cdh5-creERt2/Rosa-YFP mouse model. All animals were induced 
with tamoxifen daily during 3 days prior to wounding (D-3 to D0). At D0 mice were wounded.
YFP expression was analyzed and compared between CD34-CD45-, CD34+CD45- and finally
reported to CD34+CD45- in Cre negative control mice at day (D) 1, 3 and 5. Only D5 results are 
displayed as comparative histograms but results were concordant. YFP+ cells were only
observed in CD34+CD45- with Cre induction demarcated by yellow on the histogram. There 
were no YFP+ cells in animals that did not have any Cre activity (white). YFP+CD34+CD45-
form the proposed endothelial hierarchy as seen by EVP cells at D1 (n=3) and EVP, TA and D 
by D5 (n=3). B: Schematic representation to address the origin of EVP through the use of a
GFP-bone marrow transplantation model. Mice were wounded at either 8 or 13 weeks post-
transplantation of whole bone marrow including the endosteal layer (n=20).  
C: Flow analysis of days (D) 1 and D5 wounds from transplanted mice: all CD34+CD45-within
the wound granulation tissue were GFP negative and not bone marrow derived (n=20).  
D: By immunofluorescence and confocal microscopy imaging, all CD31+ mature vessels within 
the wound at D5 were also GFP negative. High magnification images further highlighted the 
GFP- nature of the CD31+ vessels. Only individual GFP+CD31+ cells could be observed as 
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???????????????????????????????????????????????????????????????????????????????????????????–
Yellow fluorescent protein. EVP – Endovascular Progenitor
Figure 4? Self-renewal capacity of endothelial populations. A: Schematic diagram 
demonstrating the isolation of GFP+ EVP, TA, and D, from tumors (n>40). B-C: Limiting
dilutions of endothelial cells from each population were cultured on MatrigelTM coated plates and
followed over time to obtain distinct single colonies. Time-lapse (hours) imaging demonstrated
only colony formation when GFP+ EVP cells were plated. A representative clone is figured (B) 
(n=3) and (C) quantitative colony forming capacity of EVP, TA and D from tumors and aorta in
limiting dilution (##p<0.05 vs TA; *p<0.05 vs D) (Scale bar represents 70μm; n=3).
D-E: Representative dot plots of cell suspensions obtained from MatrigelTM plugs implanted in?
mice and containing GFP+ EVP, TA and D cells (n=5) (D) and (E) percentage recovery of each
population following transplantation as reported to the initial number of cells injected (n=5) 
(##p<0.01 vs TA; **p<0.01 vs D). F: CD31/VE-Cadherin (VECAD) staining of GFP+EVP 
population derived vessels in MatrigelTM ?????????????????????????????????????????????????????
of images demonstrate that not all CD31 vessels in the MatrigelTM plugs were GFP+. Bottom 
two rows are high magnification images of vessels from top row showing double staining of
GFP/CD31 or GFP/VECAD. Results are presented as mean and distribution. EVP – 
Endovascular Progenitor; TA – Transit Amplifying; D – Definitive Differentiated; GFP – Green
Fluorescent Protein. A568 – Alexa 568 dye in secondary stain (Red). 
Figure 5? Lineage tracing reveals endovascular progenitor mobilization in wound healing.
A: Schematic representation of the lineage tracing model employing the Cdh5-creERt2/Rosa-YFP
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mouse model. All animals were induced with tamoxifen and wounded at day 0 (D0). Absence of
YFP expression was verified on CD34-CD45- cells and in Cre negative control mice at day (D) 1
and 5. Only D5 results are displayed but results were concordant. YFP+ cells were only observed 
in CD34+CD45- with Cre induction demarcated by yellow on the histogram. There were no
YFP+ cells in animals that did not have any Cre activity (white). YFP+CD34+CD45- were 
observed and related solely to EVP cells at D1, EVP and TA cells at D3 (n=3) and EVP, TA and 
D by D5 (n=3). B-C: Within the center of the granulation tissue (GT) of wounds, 
immunofluorescence demonstrated YFP+ cells at D1 are isolated CD34+, CD31/VEGFR2/CD45 
???????????????????????????????????????????????????? ??????????????????????????????????????????
????????????????????????????????????????????????????D: Low magnification image of the center
of the GT demonstration YFP+ vessels co-?????????????????????????????????????????????????
EVP – Endovascular Progenitor; TA – Transit Amplifying; D – Definitive Differentiated; YFP –
Yellow fluorescent protein; A568 – Alexa 568 secondary stain (Red).
Figure 6? Major gene expression differences between endovascular progenitors versus
terminally differentiated endothelial cells from aorta. A: Following RNAseq analysis, there 
was considerable gene expression clustering representative of each population; EVP and D 
(n=2). B: Validation of gene of interest from the D population was conducted: Ets1, Ets2, Gata2,
Fli1, Cd31, Esam, Vwf, Tie1, Cldn5, Enos, Dll1, Dll4, Hes1 and Hey1 were all upregulated >5 
fold (***p<0.001; n=3) and Sox7, Sox17 and Sox18 were upregulated >10 fold in comparison to 
EVP (***p<0.001; n=3). C: Validation of gene of interest from the EVP population was 
conducted: ?????????????????????????? and Sox9 were all upregulated >2 fold in comparison to D 
(**p<0.01; n=3). D: Immunostaining was conducted on EVP and D cells isolated from aorta. 
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IL33 and SOX9 was only observed on EVP but not D cells, further validating the RNAseq data. 
EVP did not stain for CD31 but were positive for VE-Cadherin. D cells stained for both CD31 
and VE-Cadhe??????????????????????????????????????????– Endovascular Progenitor; TA – 
Transit Amplifying; D – Definitive Differentiated; A488 – Alexa 488 secondary stain (green);
A568 – Alexa 568 secondary stain (Red).
Figure 7? Lineage tracing reveals the role of sox18 in the endothelial maturation hierarchy.
A: Schematic representation of the lineage tracing model employing the Sox18-creERt2/Rosa-YFP 
mouse model. All animals were induced with tamoxifen at day (D) 0 upon wounding.  
B: YFP expression was analyzed on three populations CD34-CD45-, CD34+CD45- and reported 
to CD34+CD45- in Cre negative control mice at days (D) 1 and 5. Only D5 results are displayed 
but results were concordant. YFP+ cells were only observed in CD34+CD45- with Cre induction 
demarcated by yellow on the histogram. There were no YFP+ cells in animals that did not have
any Cre activity (white). All YFP+CD34+CD45- cells were vascular in origin with 100% of
these cells positive for VE-Cadherin (VECAD) expression. C: YFP+CD34+CD45- were 
observed and related solely to EVP cells at D1 (n=3) and EVP, TA and D by D5 (n=3). Relative 
proportions of each population was measured at D1 and D5, demonstrating a reduction in EVP 
and a subsequent increase in D over time. Results presented as mean +/- SD.
D: Within the center of the granulation tissue (GT) of wounds, immunofluorescence 
demonstrated YFP+ Sox18 expressing cells at D1 are CD34+, CD31/VEGFR2/CD45 negative 
????????????????????????????????????? ??????????????????????????????????????????????????
posit??????????????????????????????????????E: At D5 YFP+ vessels were 
CD31+/VEGFR2+/VECAD+ but negative for lymphatic marker LYVE-???????????????????
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n=5). F: Quantification of CD31+YFP+ (27.5%; Dotted white arrow) vessels in D5 granulation 
tissue (GT) of wounds via immunofluorescence (Dotted green arrow CD31+ only; Dotted white 
???????????????????????????????????????????????????????????????? ??????- SEM). G, Lineage 
tracing was performed as described and isolectin B4 was delivered 10 minutes prior to tissue 
collection on D3 post wounding. Histogram showing EVP as isolectin negative, and TA and D as 
isolectin positive; immunofluorescence showing isolectin negative (white arrows) YFP+ vessels 
???????????????????????????????????????????????????????????????????? ????+/- SEM.  EVP –
Endovascular Progenitor; TA – Transit Amplifying; D – Definitive Differentiated; YFP – Yellow 
Fluorescent Protein; A568 – Alexa 568 secondary stain (Red). 
Figure 8. SOXF family activity is essential for de novo vessel formation. A: To determine 
whether Sox18 plays a role in maturation in the endothelial hierarchy we used the SOX18 
dominant negative mutant mice (Sox18Op+) and compared to wild type littermate controls. At 
days (D) 1, 3 and 5 wounds were harvested and absolute numbers of EVP, TA and D from wild-
type (WT) and Sox18op/+ mice were measured by flow cytometry. Numbers of EVP were 
comparable between WT and Sox18op/+, however significant differences were observed in 
absolute numbers of TA and D, demonstrating a potential maturation dysfunction in the 
Sox18op/+ (n=5) (***p<0.001). B: CD31 staining (red) in the center of granulation tissue (GT) 
from D5 wounds of WT mice displays large numbers of vessels, whereas an absence of both 
mature CD31 or VE-Cadherin (VECAD) (red) vessels in the center of the GT can be seen from 
Sox18op/+ ?????? ?????????????????????????????????????????????????????????????????????????????
n=3). Results presented as mean +/- SEM. EVP – Endovascular Progenitor; TA – Transit 
Amplifying; D – Definitive Differentiated.
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Supplemental Material 
Mathematical modeling supports a hierarchy and a differentiation sequence 
To understand better the kinetics of endothelial populations in wound granulation tissue, we 
established mathematical models comparing two scenarios for our data in the context of wound 
healing using two alternative but complementary methods (Supplementary Figure S1-5). The first was 
based on EVP giving rise to TA, which then matured to become the D population (Model 1, 
Supplementary Figure S4A). The second model hypothesized those EVP cells, which appeared 
first, could give rise to both TA or D cells without any hierarchical distinction (Model 2, 
Supplementary Figure S4B). Proliferation rates obtained from flow cytometry were applied to 
each model. We calculated expected proportions of EVP, TA and D according to each model 
for all possible differentiation variables according to the following equations. 
  
Proliferation rates were considered stable throughout the course of the model and measured 
values at day 4 (D4) were used to calibrate each population. Finally, apoptosis was estimated 
to begin from D4 only. Each population could differentiate (therefore reduce its number) 
towards another population that at each increment of time would consequently increase in 
addition to its capacity to proliferate.  
 
  
2 
 
A-Empiric method 
We calculated expected proportions of EVP, TA and D according to each model for all possible 
differentiation variables according to the following equations: 
 
NP(t) = NP(t - 1) x (1+PEVP) – Diff EVP to TA x NP(t - 1) 
- Diff EVP to D x NP(t - 1) 
 
NTA(t) = NTA(t – 1) x (1+PTA) + Diff EVP to TAx NP(t - 1) 
- Diff TA to D x N TA(t - 1) 
- N TA(t - 1) x ATA 
 
ND(t) = ND(t – 1) x (1+PD)+ Diff EVP to D x NP(t - 1) 
+ Diff TA to D x N TA(t - 1) 
- N D(t - 1) x AD 
where 
N EVP(t) = number of EVP cells at time t 
N TA(t) = number of TA cells at time t 
N D(t) = number of D cells at time t 
These values were obtained from observations for the initial time point at D1 with 158, 193 and 40 for 
EVP, TA and D respectively. 
t = time 
P EVP = Proliferation of EVP (calculated from experiments from % of cells in S or G2 phase of the cell 
cycle)=0.61 
PTA= Proliferation of TA (calculated from experiments from % of cells in S or G2 phase of the cell 
cycle)=0.88 
PD = Proliferation of D (calculated from experiments from % of cells in S or G2 phase of the cell 
cycle)=0.77 
3 
 
From these parameters the proliferation rates can be obtained as:  r = ln(1+P) that gives the following 
values: rEVP = 0.476, rTA = 0.631, rD = 0.571 
Diff EVP to TA = differentiation rate from EVP to TA 
Diff EVP to D = differentiation rate from EVP to D 
Diff TA to D = differentiation rate from TA to D 
 
ATA = apoptosis TA =10% from D4 
AD = apoptosis D =10% from D4 
 
We made the following assumptions to simplify the equation 
Diff TA to EVP = 0 
Diff D to EVP = 0 
Apoptosis in EVP = 0 
and in model 1: Diff EVP to D = 0. 
 
We then asked whether our expected values differed from our mean observed values by more 
than 1.96 standard deviations (SDs) by establishing z scores (Supplementary Tables S1-S2). 
Supplementary Figures S4C-D indicates the number of sub-populations (0-3) that fit the 
expected values (i.e. average Z score over time was below 1.96). Using the first model, if at 
each increment in time, 10-60% of EVP cells differentiated into TA and simultaneously 30-
70% of TA cells differentiated into definitive D cells, we could obtain kinetics in number (data 
not shown) and proportion (Supplementary Figure S4F) that matched our observations 
(Supplementary Figure S4E). However, when we applied differentiation variables in Model 2, 
we were unable to obtain a single combination where the model fitted within two SDs of our 
observations for all three sub-populations. Therefore, Model 2 could not substantiate our 
4 
 
observed results (Supplementary Figure S4G) as in any modeled scenario we observed 
significant divergence from our observations.  
 
B- Best fit method using minimum mean square deviation 
 
To more easily resolve EVP, TA and D cell numbers we adopted a differential equation approach 
following the same principles and same parameters as defined above. 
 
𝑑𝑁𝐸𝑉𝑃
𝑑𝑡
= 𝑟𝐸𝑉𝑃𝑁𝐸𝑉𝑃 − 𝐷𝑖𝑓𝑓𝐸𝑉𝑃 𝑡𝑜 𝑇𝐴𝑁𝐸𝑉𝑃 − 𝐷𝑖𝑓𝑓𝐸𝑉𝑃 𝑡𝑜 𝐷𝑁𝐸𝑉𝑃 
𝑑𝑁𝑇𝐴
𝑑𝑡
= 𝑟𝑇𝐴𝑁𝑇𝐴 + 𝐷𝑖𝑓𝑓𝐸𝑉𝑃 𝑡𝑜 𝑇𝐴𝑁𝐸𝑉𝑃 − 𝐷𝑖𝑓𝑓𝑇𝐴 𝑡𝑜 𝐷𝑁𝑇𝐴 − 𝐴𝑇𝐴𝑁𝑇𝐴 
𝑑𝑁𝐷
𝑑𝑡
= 𝑟𝐷𝑁𝐷 + 𝐷𝑖𝑓𝑓𝐸𝑉𝑃 𝑡𝑜 𝐷𝑁𝐸𝑉𝑃+𝐷𝑖𝑓𝑓𝑇𝐴 𝑡𝑜 𝐷𝑁𝑇𝐴 − 𝐴𝐷𝑁𝐷 
 
 
The EVP cell population is independent of the other cells and therefore the first equation has a simple 
exponential solution of the form 
𝑁𝐸𝑉𝑃(𝑡) = 𝑁𝐸𝑉𝑃(0)𝑒
𝛼𝑡 
where α = rEVP – DiffEVP to TA – DiffEVP to D. We determined the exponent by minimizing the mean square 
difference from the observations and obtained α = 0.235. 
Then using the exponential solution for NEVP we can obtain the explicit solutions for the TA and D cells. 
 
In the case of Model 2 the solutions are: 
𝑁𝑇𝐴(𝑡) = 𝑁𝑇𝐴(0)𝑒
𝑟𝑇𝐴𝑡 + 𝐷𝑖𝑓𝑓𝐸𝑉𝑃 𝑡𝑜 𝑇𝐴
𝑁𝐸𝑉𝑃(0)
𝑟𝑇𝐴 − 𝛼
(𝑒𝑟𝑇𝐴𝑡 − 𝑒𝛼𝑡) 
𝑁𝐷(𝑡) = 𝑁𝐷(0)𝑒
𝑟𝐷𝑡 + 𝐷𝑖𝑓𝑓𝐸𝑉𝑃 𝑡𝑜 𝐷
𝑁𝐸𝑉𝑃(0)
𝑟𝐷 − 𝛼
(𝑒𝑟𝐷𝑡 − 𝑒𝛼𝑡) 
where the unknown parameters are the differentiation rates, with the additional constraint: 
𝐷𝑖𝑓𝑓𝐸𝑉𝑃 𝑡𝑜 𝑇𝐴 + 𝐷𝑖𝑓𝑓𝐸𝑉𝑃 𝑡𝑜 𝐷 = 𝑟𝐸𝑉𝑃 − 𝛼 
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Comparing with the experimental data, however, we find that the observed growth of the TA cell 
population is in fact lower than the minimum of the theoretically predicted growth rate corresponding 
to the case when EVP cells only differentiate into D cells, i.e. 𝐷𝑖𝑓𝑓𝐸𝑉𝑃 𝑡𝑜 𝑇𝐴 = 0, 𝐷𝑖𝑓𝑓𝐸𝑉𝑃 𝑡𝑜 𝐷 = 𝑟𝐸𝑉𝑃 −
𝛼 with the corresponding solution 𝑁𝑇𝐴(𝑡) = 𝑁𝑇𝐴(0)𝑒
𝑟𝑇𝐴𝑡. In conclusion the observations are not 
consistent with the predictions of Model 2. 
 
In the case of Model 1, the predicted growth rate of the TA cell population is reduced by the loss due 
to their differentiation into D cells. In this case the solutions for the cell numbers are: 
𝑁𝑇𝐴(𝑡) = 𝑁𝑇𝐴(0)𝑒
(𝑟𝑇𝐴−𝐷𝑖𝑓𝑓𝑇𝐴 𝑡𝑜 𝐷)𝑡 + 𝐷𝑖𝑓𝑓𝐸𝑉𝑃 𝑡𝑜 𝑇𝐴
𝑁𝐸𝑉𝑃(0)
𝑟𝑇𝐴 − 𝐷𝑖𝑓𝑓𝑇𝐴 𝑡𝑜 𝐷 − 𝛼
(𝑒(𝑟𝑇𝐴−𝐷𝑖𝑓𝑓𝑇𝐴 𝑡𝑜 𝐷)𝑡
− 𝑒𝛼𝑡) 
 
where 𝐷𝑖𝑓𝑓𝐸𝑉𝑃 𝑡𝑜 𝑇𝐴 = 𝑟𝐸𝑉𝑃 − 𝛼 = 0.241, and 
𝑁𝐷(𝑡) = [𝑁𝐷(0) +
𝐷𝑖𝑓𝑓𝑇𝐴 𝑡𝑜 𝐷
𝑟𝐷 − 𝑟𝑇𝐴 + 𝐷𝑖𝑓𝑓𝑇𝐴 𝑡𝑜 𝐷
(𝑁𝑇𝐴(0) +
𝐷𝑖𝑓𝑓𝐸𝑉𝑃 𝑡𝑜 𝑇𝐴𝑁𝐸𝑉𝑃(0)
𝑟𝑇𝐴 − 𝐷𝑖𝑓𝑓𝑇𝐴 𝑡𝑜 𝐷 − 𝛼
)
−
𝐷𝑖𝑓𝑓𝑇𝐴 𝑡𝑜 𝐷𝐷𝑖𝑓𝑓𝐸𝑉𝑃 𝑡𝑜 𝑇𝐴𝑁𝐸𝑉𝑃(0)
(𝑟𝑇𝐴 − 𝐷𝑖𝑓𝑓𝑇𝐴 𝑡𝑜 𝐷 − 𝛼)(𝑟𝐷 − 𝛼)
] 𝑒𝑟𝐷𝑡
−
𝐷𝑖𝑓𝑓𝑇𝐴 𝑡𝑜 𝐷
𝑟𝐷 − 𝑟𝑇𝐴 + 𝐷𝑖𝑓𝑓𝑇𝐴 𝑡𝑜 𝐷
(𝑁𝑇𝐴(0) +
𝐷𝑖𝑓𝑓𝐸𝑉𝑃 𝑡𝑜 𝑇𝐴𝑁𝐸𝑉𝑃(0)
𝑟𝑇𝐴 − 𝐷𝑖𝑓𝑓𝑇𝐴 𝑡𝑜 𝐷 − 𝛼
) 𝑒(𝑟𝑇𝐴−𝐷𝑖𝑓𝑓𝑇𝐴 𝑡𝑜 𝐷)𝑡
+
𝐷𝑖𝑓𝑓𝐸𝑉𝑃 𝑡𝑜 𝑇𝐴𝑁𝐸𝑉𝑃(0)
(𝑟𝑇𝐴 − 𝐷𝑖𝑓𝑓𝑇𝐴 𝑡𝑜 𝐷 − 𝛼)(𝑟𝐷 − 𝛼)
𝑒𝛼𝑡 
 
Note, that in both solutions the only unknown parameter is 𝐷𝑖𝑓𝑓𝐸𝑉𝑃 𝑡𝑜 𝑇𝐴. We found that the mean 
square deviation from the experimental data is minimized for: 𝐷𝑖𝑓𝑓 𝑇𝐴 𝑡𝑜 𝐷 = 0.26. 
 
So overall, differentiation rates from EVP to TA  and from TA to D have a best fit at 0.241 and 
0.26 respectively which is consistent with the intervals suggested by the empirical method, Of note 
both methods do not find any solution for model 2 where EVP gives rise to both TA and D.   
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Supplementary Figure S1: Characterization of endothelial heterogeneity using flow 
cytometry. A, Flow plots (restricted to live gate) represent the exclusion of Lineage+ cells and 
subsequent gating on Lineage-CD34+ cells displays the presence of three populations based 
on CD31 and VEGFR2 levels: from left to right: EVP, TA and D. B, shows that among CD45- 
cells, all CD31+ or VEGFR2+ cells express some level of CD34 based on FMO (threshold 
figured in dashed lines) (n=6). All CD34+CD45- cells were also CD11b-, a marker of 
monocyte/macrophage populations.  C, Gated CD45- cells can be discriminated based on 
CD34 and CD31 levels of expression. In the upper right quadrant representing the endothelial 
cells, three populations of cells can be distinguished (CD34hi CD31lo (blue), CD34lo and 
CD31int (purple) and finally CD31hiCD34hi (dark blue). These populations correspond to the 
described EVP, TA and D as defined by their levels of CD31 and VEGFR2. The level of CD34 
was quantified based on Mean-Fluorescence-Intensity (MFI) for each of the endothelial 
populations. Results presented as mean +/- SEM (**p<0.01; n=3). D, Histogram plots further 
characterizing the three endothelial populations for a range of cell surface markers from cells 
obtained at day 5 post wounding. E, Amnis® analysis combining flow cytometry and imaging 
of single cells confirmed cell surface marker expression levels (Scale bar represents 30µm; 
representative images of n=3).F, Using aorta obtained from uninjured mice we demonstrate the 
existence of the 3 endothelial populations based on CD31, CD34 and VEGFR2 levels (n=4). 
Results presented as mean +/- SEM. EVP – Endovascular Progenitor; TA – Transit 
Amplifying; D – Definitive Differentiated 
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Supplementary Figure S2: Intracellular expression of CD31 and VEGFR2. A, 
Fluorescence-Minus-One (FMO) analyses were performed on cells from D5 wounds in order 
to set threshold for CD31 and VEGFR2 intracellular protein staining, on all surface 
CD34+CD45- gated cells. CD31 intracellular staining was similar to cell surface staining 
(CD31lo, CD31int, CD31hi), whereas all populations expressed intracellular VEGFR2 at a 
higher level. B, Amnis® analysis combining flow cytometry and imaging of single cells 
confirmed the intracellular marker expression for VEGFR2 but not CD31 (Scale bar represents 
30µm; representative images of n=3). C, Quantification of cell surface versus intracellular 
VEGFR2 staining using Amnis® images further confirmed the increase in VEGFR2 
intracellular expression between the three endothelial populations (*p<0.05 Intracellular vs cell 
surface; **p<0.01 D vs EVP or TA; n=3). Results presented as mean +/- SEM.  
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Supplementary Figure S3. Evolution of vascular marker staining on wound sections over 
time. Wound edge: A, IHC staining with CD34 (a, d, g, j), CD31 (b, e, h, k) and VEGFR2 (c, 
f, i, l) confirm the sequential appearance of the endothelial markers. Blood vessels labeled with 
all three markers infiltrate the granulation tissue (GT) from the wound edge (represented by 
the white dotted line). This can be clearly seen in D3 wounds (d-f) (n=3). Wound center: B, 
IHC staining with CD34 (a-d), CD31 (b-e) and VEGFR2 (c-f) confirm the absence of blood 
vessels in GT (n=3). Inserts in the bottom left corner depict the orientation of the wound. The 
red box indicates the approximate region where the image was taken. C, Representative D4 
wound section stained with CD31. White dotted line represents wound edge (Scale bars in 
whole figure represents 150µm; n=3). 
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Supplementary Figure S4. Mathematical modeling of murine endothelial hierarchy. Two 
hypothetical models were devised (Model 1 and 2) to investigate the plausibility of hierarchical 
differentiation. A-Model 1 was based on EVP giving rise to TA, which then matured to become 
the D population whereas B-Model 2 hypothesized that EVP cells could give rise to both TA 
or D cells without any hierarchical distinction. C-D, Displayed is a representation of sub-
populations that fit expected values. For example: 3 means that all three populations had 
observations within 2 standard deviation of the values calculated according to the model. Bold 
values in green represent those differentiation rates when all three sub-populations (0-3) were 
within 1.96 SDs of the observed values. In blue were figured the situations where all 
populations were within 1 SD of the mean from the calculated values. Finally * indicates 
situations where differences were below 1SD at every single time point for all three populations 
highlighting the quality of the model to reproduce our observations. This type of analysis 
supported the differentiation of the endothelial hierarchy presented in Model 1 and that of our 
observed data (n=6) over (E) Model 2. F-G Model 2 could not substantiate our observed values 
when we applied differential variables. EVP – Endovascular Progenitor; TA – Transit 
Amplifying; D – Definitive Differentiated. 
 
  
15 
 
  
16 
 
Figure S5. Lineage tracing using Sox18-creERt2/Rosa-YFP mice. A, Representative images 
demonstrating our capacity to differ between GFP and YFP signals using confocal microscopy. 
The Sox18-creERt2 also expresses GFP under the control of the Sox18 promoter. Without 
tamoxifen, only the GFP signal in Sox18-creERt2/Rosa-YFP could be detected especially upon 
use of anti-GFP antibodies. Once tamoxifen was administered, the YFP signal could be 
detected and separated from the GFP (Scale bar represents 50µm; n=2). Finally, GFP signal 
obtained from chimeric mice with a GFP transgenic bone marrow was not detected using our 
settings to obtain YFP signal. B, Lineage tracing using Sox18-creERt2/Rosa-YFP mice, injected 
on a daily basis from D0 to D5 labelled all blood vessels. Immunofluorescence images 
demonstrating CD31 and VEGFR2 staining on YFP+ vessels at D5 post-wounding (Scale bar 
represents 50μm; n=6). EVP – Endovascular Progenitor; TA – Transit Amplifying; D – 
Definitive Differentiated. YFP – Yellow Fluorescent Protein; GFP – Green Fluorescent 
Protein; A568 – Alexa 568 secondary stain (Red).  
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 Supplementary Table S1: Z scores comparing Model 1 tour observed value   
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 Supplementary Table S2: Z scores comparing Model 2 to our observed values 
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 Supplementary Table S3: Primer list for qPCR 
 
Gene Forward Primer Reverse Primer 
β-actin GTGACGTTGACATCCGTAAAGA GCCGGACTCATCGTACTCC 
Cd34 CGAGTGCCATTAAGGGAGAAA CACTTAGTTCCAGGCAGATACC 
Cd45 GAGTGCAAAGGAGACCCTATTT TGTGTCCAGAAGGGCAAATC 
Cd31 GCCAAGGCCAAACAGAAAC CTTCCACACTAGGCTCAGAAAT 
Vegfr2 GTGTACATCACCGAGAACAAGA CTGGATACCTAGCGCAAAGAG 
Tie1 GCCCTCGGATTTGGTAGGC CCGTGTGTGTGACCTTGTCT 
Vwf CTCTTTGGGGACGACTTCATC TCCCGAGAATGGAGAAGGAAC 
Cdh5 CCACTGCTTTGGGAGCCTT GGCAGGTAGCATGTTGGGG 
Egfr ATGAAAACACCTATGCCTTAGCC TAAGTTCCGCATGGGCAGTTC 
Pdgfrα ATGAGAGTGAGATCGAAGGCA CGGCAAGGTATGATGGCAGAG 
Pdgfrβ CATCCGCTCCTTTGATGATCTT GTGCTCGGGTCATGTTCAAGT 
Gata2 AAGGATGGCGTCAAGTACCAA TATCGGGTGGTGTGTTGCAG 
Fli1 TTGATTCAGCATACGGAGCGG CACTGGCTGGTTGATCCACTC 
Enos TCAGCCATCACAGTGTTCCC ATAGCCCGCATAGCGTATCAG 
Esam TTGCTGCGGGTTTTGTTCCT TCTACCGCTTCCAATTTGTTGAG 
Cldn5 GCAAGGTGTATGAATCTGTGCT GTCAAGGTAACAAAGAGTGCCA 
Ets1 TCCTATCAGCTCGGAAGAACTC TCTTGCTTGATGGCAAAGTAGTC 
Ets2 CCTGTCGCCAACAGTTTTCG GGAGTGTCTGATCTTCACTGAGA 
Dll1 CCCATCCGATTCCCCTTCG GGTTTTCTGTTGCGAGGTCATC 
Dll4 TTCCAGGCAACCTTCTCCGA ACTGCCGCTATTCTTGTCCC 
Hes1 TCAGCGAGTGCATGAACGAG CATGGCGTTGATCTGGGTCA 
Hey1 CCGACGAGACCGAATCAATAAC TCAGGTGATCCACAGTCATCTG 
Il33 ATTTCCCCGGCAAAGTTCAG AACGGAGTCTCATGCAGTAGA 
Sox7 TGGACACGTATCCCTACGGG TCCTGACATGAGGACGAGAAG 
Sox17 CCAAAGCGGAGTCTCGCAT GCCTAGCATCTTGCTTAGCTC 
Sox18 CCTGTCACCAACGTCTCGC  CAAAGCCATAGCGCCCTGA 
Sox9 AGTACCCGCATCTGCACAAC ACGAAGGGTCTCTTCTCGCT 
